Evidence map›Paper›PMID 37654657›Full record

ArticleFrontiers in medicine2023

Genetic alterations in juvenile cervical clear cell adenocarcinoma unrelated to human papillomavirus.

Yuehui Su, Yiming Zhang, Mengjiao Zhou, Ruijin Zhang, Siang Chen, Lili Zhang, Hao Wang, Dongdong Zhang, Ting Zhang, Xinqiang Li and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Yuehui SuDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yiming ZhangKey Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Mengjiao ZhouDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Ruijin ZhangKey Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Siang ChenKey Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Lili ZhangKey Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Hao WangKey Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Dongdong ZhangKey Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Ting ZhangDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xinqiang LiDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chunyan ZhangDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bingjie WangDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Shuyu YuanDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mengzhuo ZhangDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yingying ZhouDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lili CaoDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mengzhen ZhangDepartment of Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jianjun LuoKey Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
First Affiliated Hospital of Zhengzhou University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell adenocarcinoma of the cervix (CCAC) is a special type of HPV-independent cervical cancer. It has a low incidence rate, can be difficult to diagnose early, has a poor prognosis. Its peak incidence is in adolescence, which poses a great threat to women's health. Therefore, it is very important to explore the pathogenesis of cervical clear cell adenocarcinoma to guide subsequent treatment and prevention. This study analyzed 3 juvenile patients with CCAC diagnosed at the First Affiliated Hospital of Zhengzhou University. Using next-generation sequencing methods, we analyzed the pathogenesis of the patients and their close relatives by analyzing the genetic alterations of patients. CMTM5 was identified as the only shared mutated gene. Using published literature and comparative analyses of related disease-causing genes, 6 of the 19 genes (ALKBH7, MYCBP, MZF1, RNF207, RRS1, and TUSC2) were screened as genes with mutations in patients and had higher mutation rates in reproductive cancers. Pathway analysis showed that downregulated genes in non-HPV cervical cancer were mainly related to the immune system response, suggesting that non-HPV cervical cancer differs from HPV-infected cervical cancer in that the immune response is weaker, which is consistent with the weak correlation with viral infection.

Indexed as

cervical clear cell adenocarcinomaCMTM5genetic alterationshuman papillomavirusjuveniles

Identifiers

PMID37654657
PMCPMC10466801
OpenAlexW4385950561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.